472 Telazorlimab in atopic dermatitis: Phase 2b study shows improvement at 16 weeks

Authors
Category Primary study
JournalJournal of Investigative Dermatology
Year 2021
This article has no abstract
Epistemonikos ID: 9b4f25b7830768313100e2f970c5502d35c7b9ee
First added on: Feb 12, 2025